Yes C5, there are more reasons than ever based on

Yes C5, there are more reasons than ever based on actual accomplishments in 2022 that this should be trading over a penny a share than there reasons now for it to be trading under a penny. 2023 revenues will prove the company's worth and advancement in price per share. There is serious money to be made for those that follow this stock. How pain management is addressed is becoming a reality for everyone that knows about the wonderful products biel is associated with that can make a difference in peoples lives. 2023 the year of the BIEL thanks to those that never gave up on trying to make a difference.